Muhammad S. A. Khan
Research Subjects
Research Interests
Muhammad S. A. Khan has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Kamrul Hasan Sajib
Department of Rheumatology Dhaka Medical College Hospital Dhaka Bangladesh
2 shared publications - Minhaj Rahim Choudhury
Department of Rheumatology Bangladesh Medical University Dhaka Bangladesh
2 shared publications - Mohammad Mostafa Zaman
Department of Public Health and Informatics, Bangladesh Medical University, Dhaka, Bangladesh
2 shared publications - Shamim Ahmed
Faculty of Medicine Bangladesh Medical University Dhaka Bangladesh
2 shared publications - Syed Atiqul Haq
Green Life Center for Rheumatic Care and Research Dhaka Bangladesh
2 shared publications - Farhana Zaman
Dept. Of Community Medicine Universal Medical College Mohakhali Dhaka
1 shared publication
Latest Publications
- Open Access
- 24 February 2023
- Published by Wiley in Rheumatology & Autoimmunity
- Vol. 3 (1) , 43-49
HLA‐DQ and ‐DR alleles in patients with SLE: A tertiary hospital‐based case–control study in Bangladesh
Background: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by the involvement of multiple organs and autoantibody production. This study aimed to determine the association of human leukocyte antigen (HLA)‐DQ and ‐DR alleles with SLE at a tertiary hospital in Bangladesh.Methods: This case–control study was conducted in the Department of Rheumatology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh. The patients who fulfilled the 1997 revised American College of Rheumatology classification criteria for SLE were considered cases (n = 41). The controls (n = 32) were selected from the hospital staff of BSMMU, including doctors and nurses who did not suffer from any known rheumatic diseases, and there was no such disease in their first‐degree relatives. Polymerase chain reaction using a sequence‐specific primer (PCR‐SSP) in a low‐resolution typing method was carried out on blood samples collected for HLA‐DQ and ‐DR allele typing.Results: The cases and controls had comparable mean ages (31 vs. 32 years), and most cases were female (95.1% vs. 34.4%). The most frequent clinical manifestations were mucocutaneous (85.4%), followed by musculoskeletal (70.7%) and constitutional symptoms (58.5%). The cases had a significantly higher frequency of HLA‐DR2 allele compared with healthy controls (70.7% vs. 43.8%; odds ratio: 3.1; 95% confidence interval: 1.2–8.2). In addition, HLA‐DQ6 allele was found to have a significant association with mucocutaneous manifestations of the cases (88.9%, P = 0.03).Conclusions: Bangladeshi adults having HLA‐DR2 may be more susceptible to SLE. HLA‐DQ6 allele might be associated with mucocutaneous manifestations of SLE.
- 24 February 2023
- Published by Wiley in Rheumatology & Autoimmunity
- Vol. 3 (1) , 43-49
Open AccessHLA‐DQ and ‐DR alleles in patients with SLE: A tertiary hospital‐based case–control study in Bangladesh
Background: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by the involvement of multiple organs and autoantibody production. This study aimed to determine the association of human leukocyte antigen (HLA)‐DQ and ‐DR alleles with SLE at a tertiary hospital in Bangladesh.Methods: This case–control study was conducted in the Department of Rheumatology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh. The patients who fulfilled the 1997 revised American College of Rheumatology classification criteria for SLE were considered cases (n = 41). The controls (n = 32) were selected from the hospital staff of BSMMU, including doctors and nurses who did not suffer from any known rheumatic diseases, and there was no such disease in their first‐degree relatives. Polymerase chain reaction using a sequence‐specific primer (PCR‐SSP) in a low‐resolution typing method was carried out on blood samples collected for HLA‐DQ and ‐DR allele typing.Results: The cases and controls had comparable mean ages (31 vs. 32 years), and most cases were female (95.1% vs. 34.4%). The most frequent clinical manifestations were mucocutaneous (85.4%), followed by musculoskeletal (70.7%) and constitutional symptoms (58.5%). The cases had a significantly higher frequency of HLA‐DR2 allele compared with healthy controls (70.7% vs. 43.8%; odds ratio: 3.1; 95% confidence interval: 1.2–8.2). In addition, HLA‐DQ6 allele was found to have a significant association with mucocutaneous manifestations of the cases (88.9%, P = 0.03).Conclusions: Bangladeshi adults having HLA‐DR2 may be more susceptible to SLE. HLA‐DQ6 allele might be associated with mucocutaneous manifestations of SLE.
- Open Access
- 15 February 2022
- Published by Wiley in Rheumatology & Autoimmunity
- Vol. 2 (1) , 15-21
Human leukocyte antigen B polymorphism and association between HLA‐B27 and endoplasmic reticulum aminopeptidase 1 rs30187 SNP in patients with ankylosing spondylitis in Bangladesh
Objectives: To determine the association of Human leukocyte antigen B (HLA‑B) alleles with ankylosing spondylitis and the allelic association of HLA‐B27 with endoplasmic reticulum aminopeptidase 1 (ERAP1) single‐nucleotide polymorphism (SNP) rs30187 in patients with ankylosing spondylitis (AS).Methods: We studied 48 consecutively enrolled well‐defined AS patients and 48 healthy controls recruited from the outpatient clinic of the rheumatology department of Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh. To genotype HLA‐B alleles from peripheral blood DNA, we designed sequence‐specific primers for polymerase chain reaction. Sanger's sequencing method was used to detect the ERAP1 rs30187 SNP. The HLA‐B allele distributions were compared between cases and controls. To infer an allelic association between HLA‐B27 and ERAP1, allele distributions from both loci were compared using cross‐tabulations. Chi‐squared test or Fisher's exact test was used to quantify the association, and their strength of association was tested by odds ratio (OR) with 95% confidence interval (CI).Results: The frequency of HLA‐B27 was found to be higher in AS patients (60.4%) than in healthy controls (8.3%). HLA‐B27 allele had an OR of 16.8 (95% CI = 5.2–54.4) for the development of AS. Overall, 4% of AS patients had both HLA‐B27 and HLA‐B40. No significant association was found between ERAP1 rs30187 SNP and HLA‐B27 in patients with AS (OR = 1.7, 95% CI = 0.5–5.6).Conclusions: HLA‐B27 was significantly associated with AS in patients in Bangladesh. However, no association between ERAP1 rs30187 SNP and HLA‐B27 was observed.
- 15 February 2022
- Published by Wiley in Rheumatology & Autoimmunity
- Vol. 2 (1) , 15-21
Open AccessHuman leukocyte antigen B polymorphism and association between HLA‐B27 and endoplasmic reticulum aminopeptidase 1 rs30187 SNP in patients with ankylosing spondylitis in Bangladesh
Objectives: To determine the association of Human leukocyte antigen B (HLA‑B) alleles with ankylosing spondylitis and the allelic association of HLA‐B27 with endoplasmic reticulum aminopeptidase 1 (ERAP1) single‐nucleotide polymorphism (SNP) rs30187 in patients with ankylosing spondylitis (AS).Methods: We studied 48 consecutively enrolled well‐defined AS patients and 48 healthy controls recruited from the outpatient clinic of the rheumatology department of Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh. To genotype HLA‐B alleles from peripheral blood DNA, we designed sequence‐specific primers for polymerase chain reaction. Sanger's sequencing method was used to detect the ERAP1 rs30187 SNP. The HLA‐B allele distributions were compared between cases and controls. To infer an allelic association between HLA‐B27 and ERAP1, allele distributions from both loci were compared using cross‐tabulations. Chi‐squared test or Fisher's exact test was used to quantify the association, and their strength of association was tested by odds ratio (OR) with 95% confidence interval (CI).Results: The frequency of HLA‐B27 was found to be higher in AS patients (60.4%) than in healthy controls (8.3%). HLA‐B27 allele had an OR of 16.8 (95% CI = 5.2–54.4) for the development of AS. Overall, 4% of AS patients had both HLA‐B27 and HLA‐B40. No significant association was found between ERAP1 rs30187 SNP and HLA‐B27 in patients with AS (OR = 1.7, 95% CI = 0.5–5.6).Conclusions: HLA‐B27 was significantly associated with AS in patients in Bangladesh. However, no association between ERAP1 rs30187 SNP and HLA‐B27 was observed.